Roberto Alfano
Impact in
- Dermatology top 2%
- Cutaneous lymphoproliferative disorders research
- Dermatology and Skin Diseases
- Cancer and Skin Lesions
- Oncology top 10%
- Cutaneous Melanoma Detection and Management
- Cancer Immunotherapy and Biomarkers
Papers in
- Dermatology 30
- Cutaneous lymphoproliferative disorders research 12
- Cancer and Skin Lesions 7
- Dermatology and Skin Diseases 6
- Oncology 36
- Cutaneous Melanoma Detection and Management 30
- Co-authors
- Giuseppe ArgenzianoElvira MoscarellaCaterina LongoAimilios LallasTeresa RussoVincenzo PiccoloStefano CaccavaleMichele D’Amico
In The Last Decade
Roberto Alfano
90 papers receiving 984 citations
Peers
Comparison fields: 5 of 102
- Dermatology 269
- Oncology 388
- Cancer Research 105
- Epidemiology 231
- Immunology 115
Countries citing papers authored by Roberto Alfano
This map shows the geographic impact of Roberto Alfano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Alfano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Alfano more than expected).
Fields of papers citing papers by Roberto Alfano
This network shows the impact of papers produced by Roberto Alfano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Alfano. The network helps show where Roberto Alfano may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Roberto Alfano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 16 | |
| 4 | 2023 | 3 | |
| 5 | 2022 | 4 | |
| 6 | 2022 | 11 | |
| 7 | 2020 | 3 | |
| 8 | 2020 | 10 | |
| 9 | 2020 | 6 | |
| 10 | 2020 | 39 | |
| 11 | 2019 | 3 | |
| 12 | 2019 | 11 | |
| 13 | 2019 | 9 | |
| 14 | 2019 | 1 | |
| 15 | 2018 | 69 | |
| 16 | 2017 | 57 | |
| 17 | 2017 | 1 | |
| 18 | 2016 | 11 | |
| 19 | 2016 | 20 | |
| 20 | 2016 | 21 |
About Roberto Alfano
Roberto Alfano is a scholar working on Dermatology, Oncology, Epidemiology, Immunology and Cancer Research, having authored 93 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (30 papers), Nonmelanoma Skin Cancer Studies (21 papers), Cutaneous lymphoproliferative disorders research (12 papers), Cancer and Skin Lesions (7 papers), Melanoma and MAPK Pathways (6 papers), Dermatology and Skin Diseases (6 papers), Genetic and rare skin diseases. (5 papers) and Autoimmune Bullous Skin Diseases (5 papers). The work is most often cited by research in Dermatology (269 citations), Oncology (388 citations), Cancer Research (105 citations), Epidemiology (231 citations) and Immunology (115 citations). Roberto Alfano has collaborated with scholars based in Italy, Greece and Austria. Frequent co-authors include Giuseppe Argenziano, Elvira Moscarella, Caterina Longo, Aimilios Lallas, Teresa Russo, Vincenzo Piccolo, Stefano Caccavale, Michele D’Amico, Maria Consiglia Trotta and Renato Franco. Their work appears in journals such as Journal of the European Academy of Dermatology and Venereology, International Journal of Molecular Sciences, Dermatology, Dermatologic Therapy and Journal of the American Academy of Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.